Consuming a marijuana-based drug may be safe in treating children with severe epilepsy, results of a clinical trial has showed.
Following treatment with cannabidiol — a non-psychoactive compound found in marijuana — about one in five children were described as much or very much improved from their baseline, while around half reported none, or a very slight improvement, Xinhua news agency reported.
While the trial was conducted on a small group of children with severe epilepsy, it showed that the drug had a manageable side effect profile, but only showed extensive symptom relief for a brief number of patients.
The trial “involved the sickest children with epilepsy — children who are having seizures many times per day, who have been recently hospitalized for their epilepsy, and have failed on average about nine anti-epilepsy drugs before,” said lead author John Lawson, paediatric neurologist at Sydney’s Children’s Hospital.
“The main aim of the study was about